logo
calendar21 Oktabr 2019
view35
Main language:Russian

ANALYSIS OF DYNAMICS OF REGISTRATION OF ANTIDEPRESSANTS BASED ON THE ACTIVE SUBSTANCE IN THE REPUBLIC OF UZBEKISTAN

Field of Science:
pdf

20191021052506_Farmvest....pdf

PDF

Oʻzbekiston farmatsevtik xabarnomasi

Oʻzbekiston farmatsevtik xabarnomasi

Publish Articlesee more

ARTICLE ANNOTATION

quote
An analysis of the dynamics of the registration of antidepressants on the parameter of the active substance was conducted in the Republic of Uzbekistan by using the data of the state register (the period from 2006 to 2016). Based on the analysis, the trends and specifics of the domestic market segment of antidepressants have been identified. Results that can be used to further substantiate marketing decisions by both domestic manufacturers and distributors, among others.

AUTHORS

A.Raximov

Тошкент фармацевтика институти

D.Saipova

Тошкент фармацевтика институти

Tags

# антидепрессанты# ингибиторы МАО# норадреналин# серотонин# «rapid» быстрые антидепрессанты# амитриптилин# эсциталопрам# контент анализ# маркетинговая среда# индекс обновления# Antidepressants# MAO inhibitors# norepinephrine# serotonin# rapid antidepressants# amitriptyline# escitalopram# content analysis# marketing environment# update index# антидепрессантлар# МАО ингибиторлари# «rapid» тез антидепрессантлар# маркетинг муҳити# янгиланиш индекси

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

ROI:

https://eroi.uz/11.0014/A1019-0029

DOI:

Not Available

References

1. «Здравоохранение Узбекистана», Статистический сборник. Государственный комитет Республики Узбекистан по статистике. Ташкент 2015 г.

2. http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001547 (Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010)

3. https://www.washingtonpost.com/news/worldviews/wp/2013/11/07/a-stunning-map-of-depressionrates-around-the-world/?utm_term=.1caf7d2d77b6 (A stunning map of depression rates around the world)

4. Государственный Реестр лекарственных средств и медицинских изделий Республики Узбекистан. – за 2006-2016 гг.

5. Priest R. G., Baldwin D. S. Depression and anxiety. — London: Martin Dunitz, 1994. — 82 с.

6. http://www.rmj.ru/articles/obshchie-stati/Klinicheskoe_primenenie_sovremennyh_antidepressantov/ (Клиническое применение современных антидепрессантов).

7. https://www.jnj.com/media-center/press-releases/esketamine-recieves-breakthrough-therapydesignation-from-us-food-and-drug-administration-for-major-depressive-disorder-with-imminent-risk-ofsuicide (Esketamine Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Major Depressive Disorder with Imminent Risk for Suicide)